PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity
Critical priority
What you should do
- 1Continue taking your medication.
- 2Not treating a condition may pose a greater health risk than potential nitrosamine exposure.
- 3Contact your health care provider:to discuss treatment options if you're using a recalled productif you have taken a recalled product and are concerned about your healthAsk your pharmacist if you're not sure if the product you're taking has been recalled.
The issue
Contamination
Affected product
PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg
Where it was sold
QCReported in the official notice — confirm there.
Issued by
Health Canada — Drugs and health products
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.